Schedule 13G ownership disclosure
Sienna Biopharmaceuticals, Inc.
Security class unavailable · CUSIP: 82622H108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-021670
- Form type
- SC 13G
- Filer
- PFM Health Sciences, LP
- CIK
- CIK 1442756
- Filed
- Feb 14, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership